You just read:

Global Blood Therapeutics to Host Investor Event on Friday, June 10 to Review GBT440 Data in Sickle Cell Disease Being Presented at the European Hematology Association's 21st Congress

News provided by

Global Blood Therapeutics, Inc.

Jun 02, 2016, 08:00 ET